Dr Bruce Berman, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: I'm joined today by Dr Bruce Berman from sunny Florida in the US thanks for joining me, Bruce. 

Dr Bruce Berman: My pleasure. 

Dr Akbar Khan on Low Dose Naltrexone, LDN Radio Show 2013 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Akbar Khan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Akbar Khan on Cancer, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today we're joined by Dr Akbar Khan, who works with LDN and cancer in his Medicor Cancer Centres. He has treated over 2000 patients with LDN, so we are very interested in hearing what he has to say.

Low Dose Naltrexone in Endometrial Intraepithelial Neoplasia (Abstract)

Pain Med
Epub 07 July 2021
https://pubmed.ncbi.nlm.nih.gov/34240210/

Woman on low dose naltrexone for pain management of chronic lumbar radicular pain had resolution of endometrial intraepithelial neoplasia (EIN).
 

Carrie Forrest, MBA, MPH (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Carrie takes LDN for an autoimmune thyroid disorder/thyroid cancer, PCOS, chronic fatigue, and migraines.

Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy

Int Immunopharmacol
11 May 2021
https://pubmed.ncbi.nlm.nih.gov/33989971/

Breast and Colon Cancer by Dr Yusuf Saleeby 2021 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Yusuf Saleeby: General Preventive and Integrative Medicine/ Restorative Medicine / Functional Medicine, presents on Breast and Colon Cancer.

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888

Low dose naltrexone: Harnessing the body's own chemistry to treat human ovarian cancer

Science Daily
13 July 2011
https://www.sciencedaily.com/releases/2011/07/110712143012.htm

Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy

Int Immunopharmacol
August 2018
https://pubmed.ncbi.nlm.nih.gov/29885638/